Join us in Frankfurt on February 18th, 2020 to watch Pavel from our team present Quinta-Analytica’s robust and versatile LC/MS/MS detection methods at the European Compliance Academy’s Nitrosamine Impurities urgent compliance meeting.

As one of the biggest challenges to the pharma industry today, and with all Marketing Authorization Holders now obligated to evaluate the risks of their products containing chemically synthesized APIs, its’ clear that potential Nitrosamine contamination in drug substances is seen as a real risk.

Qunita-Analytica’s detection methods are based on isotopically labeled standards, and are customized to each specific scenario. Already proven to be applicable on a broad range of nitrosamines and matrixes, and capable of reaching LOQ down to 20 ppb, our team are able to offer highly sensitive testing beyond the general scope of Sartans, Ranitidine and Metformin and support our clients with specific cases including customer-specific APIs, excipients, semi-finished products and more.

To learn more about how we can help your organization with supply continuity, contact Pavel from our commercial team at pavel.pihera@quinta.cz.

More information about the Nitrosamine Impurities event can be found here. If you’re going to be in the are or atending the event, please let us know and we’ll be pleased to meet with you!

Additional News

  • 18 March 2024

    News from our newly opened clinic in Ostrava

    Our new Clinic in Ostrava (CZ) is gaining momentum step by step; therefore, we have some interesting news for you from the center of the action.

  • 19 December 2023

    Happy new year 2024

    As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

  • 4 December 2023

    Our new clinical unit in Ostrava comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.